LMAT

LMAT Other Income/Expenses (Net)

$7.42MTTM · USD

Period ending:

LMAT FY Other Income/Expenses (Net)USD
LMAT FY Other Income/Expenses (Net)2001-12-31: -$320.00K2002-12-31: $128.00K2003-12-31: -$20.66M2004-12-31: -$451.00K2005-12-31: -$842.00K2006-12-31: $159.00K2007-12-31: $1.58M2008-12-31: $109.00K2009-12-31: $266.00K2010-12-31: $10.00K2011-12-31: $62.00K2012-12-31: -$247.00K2013-12-31: -$190.00K2014-12-31: -$20.00K2015-12-31: -$89.00K2016-12-31: -$94.00K2017-12-31: $3.00K2018-12-31: $235.00K2019-12-31: $496.00K2020-12-31: -$1.43M2021-12-31: -$2.14M2022-12-31: $661.00K2023-12-31: $2.76M2024-12-31: $4.62M2025-12-31: $7.27M$7.27M-$20.66M
2001-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

LMAT other income/expenses (net) history

Net other income and expenses outside core operations. The available annual fiscal periods series contains 25 observations from Dec 31, 2001 to Dec 31, 2025.

Lemaitre Vascular Inc Other Income/Expenses (Net) — Annual fiscal periods (USD)
Period endingOther Income/Expenses (Net) (USD)
7,272,000
4,619,000
2,763,000
661,000
-2,138,000
-1,432,000
496,000
235,000
3,000
-94,000
-89,000
-20,000
-190,000
-247,000
62,000
10,000
266,000
109,000
1,581,000
159,000
-842,000
-451,000
-20,664,000
128,000
-320,000

Compare other income/expenses (net)

All LMAT financial metrics · LMAT stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.